Aurobindo Pharma's net profit fell 10.2 per cent Y-o-Y to ₹824 crore in Q1FY26, as against ₹918 crore in the same quarter ...

Aurobindo Pharma Limited announced mixed performance during the quarter ended June 2025. The business reported a consolidated net profit of ₹824.20 Crore in the quarter under review, down by 10.20% on ...

Aurobindo Pharma fell 1.10% to Rs 1,078.95 after the company's consolidated net profit tumbled 10.3% to Rs 824.75 crore despite of 4.5% increase in revenue from operations to Rs 7791.77 crore in Q1 ...

Mumbai :Aurobindo Pharma Limited on Monday reported a 10.2 per cent year-on-year (YoY) drop in consolidated net profit to Rs ...

Mumbai: Aurobindo Pharma Ltd has posted a 10.2 percent year-on-year (YoY) decline in consolidated net profit for the first ...

Aurobindo Pharma's Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA), margins and net profit was also ...

One 97 Communications: Antfin in its clean out trade, to sell 5.84% stake at Rs 1020 apiece. The block deal size is Rs 3,800 ...

Domestic equity benchmarks halted a two-day losing streak amid buying in IT, energy and auto shares on Monday, though selling ...

Alembic Pharmaceuticals reports 14.6% profit rise in Q1, driven by strong U.S. and India sales, launching 4 new products.

DLF's consolidated net profit jumped 18.1% to Rs 762.67 crore in Q1 FY26, compared with Rs 645.61 crore in Q1 FY25. Net sales increased 99.4% YoY to Rs 2,716.70 crore in Q1 FY26.

Track top stocks like Tata Motors, IndusInd Bank, Kaynes Tech, and more as key updates and earnings could drive action ...